Accessibility: Skip TopNav
Efficacy in Early AD Patients
Buntanetap showed statistically significant efficacy and safety in both carriers and non-carriers of Apolipoprotein E4 (APOE4), a genetic cause of AD.
Format
JPEG
Source
Annovis Bio, Inc.
Downloads
Original
Large
Medium
Small